Building the infrastructure and personnel to rapidly analyse large datasets of patient genomic information.
The Bioinformatics Platform will be generating massive datasets of patient information, mapping their entire genome – as opposed to a single panel of DNA – to provide improved diagnosis and more targeted and effective treatments.
The platform is vital in our ability to roll out genomic sequencing for clinicians and patients, to rapidly provide details to inform prompt treatment change and better chances for a positive response.
Professor Oliver Hofmann and his team, in collaboration with Illumina, are developing systems that reduce the time taken to sequence patient data and improve reliability.
A new Illumina cloud-computing based platform will allow the University of Melbourne Centre for Cancer Research (UMCCR) team to analyse the large sets of data in parallel, drastically reducing analysis time for patients from 72 hours to as little as 12 hours.
Platform research lead: Professor Oliver Hofmann
Professor Oliver Hofmann's Genomics Platform Group works to improve the scalability and reliability of sequencing workflows, enable better detection of changes in cancer genomes, and make tumour data accessible in real-time.